Most Valuable CEO #8 – John C. Martin, Ph.D.

#8 John C. Martin, Ph.D., Gilead Sciences
#8 John C. Martin, Ph.D.


Gilead Sciences

This biopharmaceutical company has 14 marketed products and over 4200 employees on four continents. Gilead had almost $8 billion in revenues in 2010.

Gilead Sciences consistently ranks among top performers in the Wealth Creation Index. Among the consistent top performers, Mike Burdi, Applied Finance Group senior analyst, finds a common thread: “Do your customers care whether you stay in business? It’s one thing to say that one is customer-focused; most claim to be as a matter of course. But would your customers really miss not having access to what you offer?” For Gilead customers, that answer is yes.

Score 2010 Score % Change In Score Market Value/Invested Capital Three-Year EM EM Change Mgmt Quality
92.8 86.7 7.0% B A A A

#9 Lothar Maier, Linear Technology »« #7 David J. Lesar, Halliburton


  • Get the CEO Briefing

    Sign up today to get weekly access to the latest issues affecting CEOs in every industry
  • upcoming events